| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -7.8e-05 | 1 |